Enliven Therapeutics Up Over 16%, on Track for Largest Percent Increase Since April 2024 -- Data Talk

Dow Jones
2025/06/14

Enliven Therapeutics, Inc. ( ELVN ) is currently at $22.89, up $3.23 or 16.43%

 

--Would be highest close since Jan. 8, 2025, when it closed at $24.15

--On pace for largest percent increase since April 11, 2024, when it rose 20.18%

--Currently up three of the past four days

--Currently up two consecutive days; up 16.76% over this period

--Best two day stretch since the two days ending June 3, 2025, when it rose 23.02%

--Up 28.81% month-to-date

--Up 1.73% year-to-date

--Down 89.57% from its all-time closing high of $219.48 on June 11, 2020

--Up 5.48% from 52 weeks ago (June 14, 2024), when it closed at $21.70

--Down 22.54% from its 52-week closing high of $29.55 on Nov. 6, 2024

--Up 53.52% from its 52-week closing low of $14.91 on April 10, 2025

--Traded as high as $23.49; highest intraday level since Jan. 10, 2025, when it hit $24.21

--Up 19.48% at today's intraday high; largest intraday percent increase since April 11, 2024, when it rose as much as 31.18%

 

All data as of 2:21:27 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

June 13, 2025 14:24 ET (18:24 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10